Abstract
The postmenopausal patient with new-onset vaginal bleeding should be assessed with transvaginal pelvic sonography. An endometrial thickness of ≤4 mm (ACOG) (or 5 mm by other societies) is a safe cutoff to defer endometrial sampling as the risk or endometrial malignancy is 1% unless the patient has persistent or intermittent bleeding where the risk may be higher [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith-Bindman R, Kerlikowske K et al (1998) Ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280(17):1510
Beddy P, Moyle P et al (2012) Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 262(2):530
Park JY, Kim EN et al (2008) Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 108(3):486
Fung-Kee-Fung M, Dodge J et al (2006) Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 101(3):520
Prat J (2014) FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol 133:401–404
www.cancer.gov/cancertopics/pdq/screening/ovarian/healthprofessional/allpages
National Comprehensive Cancer Network (NCCN)
Buys SS, Partridge E et al (2011) Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. PLCO project team. JAMA 305(22):2295
Kobayashi H, Yamada Y et al (2008) A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer 18(3):414
Menon U, Gentry-Maharaj A, Hallett R, Ryan A et al (2009) Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian cancer screening (UKCTOCS). Lancet Oncol 10(4):327
JR Jr VN, Miller RW et al (2011) Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol 118(6):1212
NCCN Guidelines Version 2.2012: Epithelial ovarian cancer/fallopian tube cancer/ primary peritoneal cancer. http://www.nccn.org.laneproxy.stanford.edu/professionals/physician_gls/pdf/ovarian.pdf
Benedet JL, Bender H et al (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obstet 70(2):209
Elit L, Fyles AW et al (2009) Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol 114(3):528
Salani R, Backes FJ et al (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of gynecologic oncologists recommendations. Am J Obstet Gynecol 204(6):466
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Hilaris, G.E. (2018). Clinical Implications of Gynecologic Cancer. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-68873-2_47
Download citation
DOI: https://doi.org/10.1007/978-3-319-68873-2_47
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68872-5
Online ISBN: 978-3-319-68873-2
eBook Packages: MedicineMedicine (R0)